Search results for: 'merger and acquisition deaf and alliance of 2017'
- Did you mean
- merger and acquisition deal and alliance of 2025
- Related search terms
- Merger & Acquisition Deals
- Acquisition Terms and Agreements in Pharma
- acquisition texas and agreements in pharma
- merger+and+acquisition+deal+and+alliance+of+2022
- merger+and+acquisition+deaf+and+alliance+of+2017
-
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025August 2025$4,995.00
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Central Nervous System (CNS) Collaboration and Licensing Deals 2020-2025April 2025$3,995.00
Central Nervous System (CNS) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2025
Learn More -
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2025September 2025$3,995.00
Analyze co-development deals in pharma and biotech from 2016 to 2025. Includes financials, deal terms, and access to actual contracts where available.
Learn More -
Genomic Collaboration and Licensing Deals 2018-2025May 2025$3,995.00
Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More -
In Vitro Diagnostic Collaboration and Licensing Deals 2016-2025May 2025$3,995.00
In Vitro Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Licensing Deals in Pharmaceuticals 2019-2025July 2025$4,995.00
Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025May 2025$3,995.00
Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025May 2025$3,995.00
Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2025May 2025$3,995.00
Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025July 2025$3,995.00
Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More